Sana Biotechnology Q2 Adj. EPS $(0.13) Beats $(0.15) Estimate
Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.15) by 13.33 percent. This is a 18.75 percent increase over losses of $(0.16) per share
Sana Biotechnology lost less money per share than experts expected, which is good news for a company still in research mode. When a company doing cutting-edge work spends less than predicted, it shows smart money management worth noticing.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.